Report Overview

The growing awareness about the significant potential of AI-based tools in elderly care and an increasingly high demand for digitalization in healthcare are projected to propel the expansion of the UAE artificial intelligence (AI) in healthcare market during the forecast period between 2023 and 2029.

UAE Artificial Intelligence (AI) in Healthcare Market - Industry Trends & Forecast Report, 2029

UAE artificial intelligence (AI) in healthcare market size was estimated at USD 119 million in 2022. During the forecast period between 2023 and 2029, the size of UAE artificial intelligence (AI) in healthcare market is projected to grow at a CAGR of 42.28% reaching a value of USD 987.6 million by 2029. Major growth drivers for the UAE artificial intelligence (AI) in healthcare market include rising investments in AI systems, a surge in demand for intelligent solutions, and a growing adoption of cloud technology. The UAE's healthcare system is renowned globally, with an impressive ratio of 181 doctors per 100,000 people. Lifestyle diseases, like obesity (affecting one-third of adults) and diabetes (affecting one in five), are on the rise, prompting a demand for higher-quality healthcare services, particularly among the relatively affluent population. In recent years, the UAE has embraced AI in healthcare. Substantial investments by the government have facilitated an efficient healthcare system that leverages AI for improved medical services. AI-powered algorithms aid in precise and rapid disease diagnosis and treatment. Medical images and patient data in electronic health records are analyzed to identify patterns, allowing for personalized and effective treatments. AI is also employed in remote patient monitoring, enabling timely interventions. To drive innovation, the Dubai Health Authority (DHA) established the Dubai Health Innovation Centre, focused on testing and developing healthcare technologies, including AI solutions. Private companies, like Dubai-based startup Vezeeta, are also investing in AI-powered platforms to assist patients in finding doctors and booking appointments online.

UAE Artificial Intelligence (AI) in Healthcare Market – Overview

The UAE artificial intelligence (AI) in healthcare market refers to the sector's use and integration of AI technologies and solutions to enhance various aspects of healthcare services in the UAE. This includes the application of AI algorithms and machine learning techniques to analyze medical data, medical imaging, electronic health records, and other healthcare-related information to aid in diagnosis, treatment, personalized care, and decision-making processes. The market encompasses investments, developments, and adoption of AI-driven solutions aimed at improving the overall efficiency, accuracy, and quality of healthcare delivery in the UAE.

UAE Artificial Intelligence (AI) in Healthcare Market

Growth Drivers

Push for Digitalization in Healthcare

The UAE's emphasis on developing a robust healthcare system fuelled by digitalization has been a major growth driver. Recognizing the potential of artificial intelligence (AI) to revolutionize patient care, the government invested significantly in healthcare infrastructure and advanced technology. AI-powered healthcare solutions have transformed diagnostics, prediction, and overall patient outcomes. Machine learning algorithms analyse vast patient data, uncovering hidden patterns to provide personalized treatments. Moreover, digitalization streamlined administrative tasks, enhancing patient experiences. The commitment to digital healthcare is set to drive further research and development, encouraging collaborations among technology companies, research institutions, and healthcare providers. As a result, the UAE's healthcare sector is poised to achieve new heights of excellence, with AI at its forefront.

Growing Awareness about Significant Potential of AI-based Tools in Elderly Care

The UAE's aging population has spurred a growing interest in AI-based tools for elderly care. Artificial intelligence (AI) offers innovative solutions to address the unique needs of the elderly, making it a significant growth driver in the healthcare sector. AI-powered remote patient monitoring enables continuous health tracking and timely interventions, reducing hospital readmissions. Assistive robots with sophisticated algorithms provide support and companionship, promoting independent living. AI's data analysis capabilities create personalized treatment plans, optimizing care for elderly patients based on their medical histories. The potential for AI in elderly care is expected to expand as the UAE invests in related R&D projects and activities. Advancements in geriatric medicine, diagnosis, and tailored treatment regimens are on the horizon, enhancing the quality of life for the elderly population. Embracing AI-based tools will undoubtedly shape the future of elderly care in the UAE.

Restraints

Lack of Requisite Infrastructure for Robust AI Implementation

in the UAE, the growth of AI in healthcare faces several obstacles. A major challenge is the limited data information exchange among healthcare providers, hindered by the compartmentalized nature of storage facilities. This hampers the development of AI solutions that could benefit the entire healthcare system. Additionally, there is a shortage of trained individuals proficient in creating and implementing AI-powered healthcare solutions, despite the increasing popularity of AI in the country.

Impact of COVID-19 on UAE Artificial Intelligence (AI) in Healthcare Market

COVID-19 pandemic had a mixed impact on the UAE artificial intelligence (AI) in healthcare market. As the healthcare system faced unprecedented challenges, there was an accelerated adoption of AI-powered solutions to manage patient care and optimize resources. AI played a crucial role in areas such as diagnostics, telemedicine, and drug discovery. Remote patient monitoring and AI-based analytics also aided in tracking and predicting infection trends. Moreover, the pandemic highlighted the importance of AI in enhancing healthcare preparedness and response capabilities. The increased reliance on AI during COVID-19 shaped the future of healthcare, fostering further growth and innovation in the UAE market.

UAE Artificial Intelligence (AI) in Healthcare Market

Segmental Coverage

UAE Artificial Intelligence (AI) in Healthcare Market – By Offering

By offering, the UAE artificial intelligence (AI) in healthcare market is divided into Hardware, Software, and Services segments. The services segment holds the highest share in the UAE artificial intelligence (AI) in healthcare market by offering. The services segment in the AI in healthcare market often includes consulting, implementation, training, maintenance, and support services for AI solutions. This segment's significance can be attributed to the need for customization and seamless integration of AI applications in healthcare, along with the complexity of implementation and the rapid advancements in AI technology. Moreover, service providers can ensure compliance with regulations and data security requirements. Outsourcing AI-related services may also offer cost-effectiveness for healthcare organizations.

UAE Artificial Intelligence (AI) in Healthcare Market – By Technology

Based on technology, the UAE artificial intelligence (AI) in healthcare market is divided into Machine Learning (ML), Natural Language Processing (NLP), Context-Aware Computing, and Computer Vision segments.

UAE Artificial Intelligence (AI) in Healthcare Market – By End-Use Application

Based on end use application, the UAE artificial intelligence (AI) in healthcare market is divided into Patient Data & Risk Analysis, Inpatient Care & Hospital Management, and Medical Imaging & Diagnostics segments. The medical imaging & diagnostics segment holds the highest share in the UAE artificial intelligence (AI) in healthcare market by end-use application, due to a high demand for precision in disease detection and treatment planning, the increasing volume of medical imaging data, advancements in AI algorithms, cost-effectiveness, and the rising prevalence of chronic diseases.

UAE Artificial Intelligence (AI) in Healthcare Market – By End User

On the basis of end user, the UAE artificial intelligence (AI) in healthcare market is divided into Hospitals & Providers, Patients, Pharmaceutical & Biotechnology Companies, and Healthcare Payers segments.  The hospitals & providers segment holds the highest share in the UAE artificial intelligence (AI) in healthcare market by end user. Hospitals and healthcare providers are early adopters of advanced technologies, seeking to enhance patient care and operational efficiency. AI's applications in risk prediction, personalized treatment plans, and resource optimization align with their goals. With abundant patient data available, AI can analyze and provide valuable insights for evidence-based decision-making.

Competitive Landscape

Major players operating in the UAE artificial intelligence (AI) in healthcare market include IBM Watson Health, Google Health, NVIDIA, Microsoft Healthcare, Cerner Middle East and Africa, Healthigo (ARE), Mubadala Healthcare (ARE), and NMC Healthcare (ARE). To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• in December 2022 - Dubai played host to a regional conference on Artificial Intelligence and Healthcare, organized in partnership with the UAE Artificial Intelligence Office.

• In August 2022 - The Department of Health - Abu Dhabi (DOH) and Malaffi, the health information exchange system, formed a collaboration to utilize AI for predicting patients' future disease risks.

Scope of the Report

By Offering

• Hardware

• Software

• Services

By Technology

• Machine Learning

• NLP

• Context-Aware Computing

• Computer Vision

By End-Use Application

• Patient Data & Risk Analysis

• Inpatient Care & Hospital Management

• Medical Imaging & Diagnostics

By End User

• Hospitals & Providers

• Patients

• Pharmaceutical & Biotechnology Companies

• Healthcare Payers